MOESM2 of Phase I/II intra-patient dose escalation study of vorinostat in children with relapsed solid tumor, lymphoma, or leukemia
Cornelis van Tilburg
Till Milde
Ruth Witt
Jonas Ecker
Thomas Hielscher
Angelika Seitz
Jens-Peter Schenk
Juliane Buhl
Dennis Riehl
Michael Frühwald
Arnulf Pekrun
Claudia Rossig
Regina Wieland
Christian Flotho
Uwe Kordes
Bernd Gruhn
Thorsten Simon
Christin Linderkamp
Felix Sahm
Lenka Taylor
Angelika Freitag
Jürgen Burhenne
Kathrin Foerster
Andreas Meid
Stefan Pfister
Irini Karapanagiotou-Schenkel
Olaf Witt
10.6084/m9.figshare.11352698.v1
https://springernature.figshare.com/articles/presentation/MOESM2_of_Phase_I_II_intra-patient_dose_escalation_study_of_vorinostat_in_children_with_relapsed_solid_tumor_lymphoma_or_leukemia/11352698
Additional file 2: Figure S2. a Plot of pairwise correlations (Spearman) of baseline concentrations of individual cytokines. b Heatmap of baseline concentrations (Gehan u-score) of a selection of 9 cytokines. c Longitudinal analysis of mean values of cytokines, separated by MTD groups. d Longitudinal analysis of mean values of cytokines, separated by best response groups.
2019-12-11 10:43:46
Vorinostat
Intra-patient dose escalation
Dose-response
Cytokine
Child
HDAC